Compare QGEN & MOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QGEN | MOH |
|---|---|---|
| Founded | 1986 | 1980 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 8.9B |
| IPO Year | 1996 | 2003 |
| Metric | QGEN | MOH |
|---|---|---|
| Price | $55.53 | $194.41 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 13 |
| Target Price | $48.84 | ★ $210.92 |
| AVG Volume (30 Days) | ★ 2.4M | 1.2M |
| Earning Date | 02-04-2026 | 02-05-2026 |
| Dividend Yield | ★ 4.33% | N/A |
| EPS Growth | ★ 331.25 | N/A |
| EPS | 1.94 | ★ 16.24 |
| Revenue | $2,070,781,000.00 | ★ $42,842,000,000.00 |
| Revenue This Year | $7.12 | $15.20 |
| Revenue Next Year | $5.95 | $4.03 |
| P/E Ratio | $28.76 | ★ $11.98 |
| Revenue Growth | 5.32 | ★ 14.11 |
| 52 Week Low | $39.61 | $133.40 |
| 52 Week High | $57.82 | $359.97 |
| Indicator | QGEN | MOH |
|---|---|---|
| Relative Strength Index (RSI) | 75.30 | 71.26 |
| Support Level | $46.07 | $183.78 |
| Resistance Level | $57.82 | $194.70 |
| Average True Range (ATR) | 1.91 | 7.04 |
| MACD | 0.93 | 0.85 |
| Stochastic Oscillator | 76.38 | 95.75 |
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
Molina provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in just four states—California, New York, Texas, and Washington—account for over half of its enrollees.